Protara Therapeutics, Inc. (TARA) — Dilution Risk Analysis
Current Snapshot
Protara Therapeutics, Inc. (TARA) has a DilutionWatch score of 34/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 34/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: XBRL 1, 4 8, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-4616-xbrl_warrant |
| 4 | 2026-04-02 | 0001213900-26-039328 |
| 8-K | 2026-03-30 | 0001213900-26-035971 |
| 4 | 2026-01-27 | 0001213900-26-008223 |
| 4 | 2026-01-27 | 0001213900-26-008224 |
| 4 | 2026-01-27 | 0001213900-26-008221 |
| 4 | 2026-01-27 | 0001213900-26-008222 |
| 4 | 2026-01-22 | 0001213900-26-006707 |
| 4 | 2026-01-22 | 0001213900-26-006708 |
| 4 | 2026-01-22 | 0001213900-26-006709 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 28 months | Source |
| Three-year share count growth | 419.98% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 34/10) Source
- Cash Runway
- 28 months Source
- Share Count Growth (3-Year)
- 419.98% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.